312 related articles for article (PubMed ID: 9255748)
1. Comparison of transvaginal ultrasonography and endometrial biopsy in endometrial surveillance in postmenopausal HRT users.
Hänggi W; Bersinger N; Altermatt HJ; Birkhäuser MH
Maturitas; 1997 Jun; 27(2):133-43. PubMed ID: 9255748
[TBL] [Abstract][Full Text] [Related]
2. Placental protein 14 (PP14) does not predict endometrial status under hormone replacement therapy.
Haenggi W; Bersinger NA; Altermatt HJ; Birkhaeuser MH
Gynecol Endocrinol; 1997 Feb; 11(1):51-7. PubMed ID: 9086340
[TBL] [Abstract][Full Text] [Related]
3. [The influence of a tibolone therapy on endometrium in postmenopausal women].
Szlendak-Sauer K; Wierzba W; Radowicki S
Ginekol Pol; 2008 Nov; 79(11):758-61. PubMed ID: 19140498
[TBL] [Abstract][Full Text] [Related]
4. Impact on uterine bleeding and endometrial thickness: tibolone compared with continuous combined estradiol and norethisterone acetate replacement therapy.
Dören M; Rübig A; Coelingh Bennink HJ; Holzgreve W
Menopause; 1999; 6(4):299-306. PubMed ID: 10614676
[TBL] [Abstract][Full Text] [Related]
5. Long-term effects of tibolone on the endometrium as assessed by bleeding episodes, transvaginal scan and endometrial biopsy.
Bruce D; Robinson J; Rymer J
Climacteric; 2004 Sep; 7(3):261-6. PubMed ID: 15669550
[TBL] [Abstract][Full Text] [Related]
6. Ultrasonographic measurement of endometrial thickness during hormonal replacement therapy in postmenopausal women.
Affinito P; Palomba S; Pellicano M; Sorrentino C; Di Carlo C; Morgera R; Arienzo MP; Nappi C
Ultrasound Obstet Gynecol; 1998 May; 11(5):343-6. PubMed ID: 9644774
[TBL] [Abstract][Full Text] [Related]
7. Transdermal sequential and continuous hormone replacement regimens with estradiol and norethisterone acetate in postmenopausal women: effects on the endometrium.
Johannisson E; Holinka CF; Arrenbrecht S
Int J Fertil Womens Med; 1997; 42 Suppl 2():388-98. PubMed ID: 9397386
[TBL] [Abstract][Full Text] [Related]
8. Endometrial response in estrogen replacement therapy quarterly combined with a progestogen.
Boerrigter PJ; van de Weijer PH; Baak JP; Fox H; Haspels AA; Kenemans P
Maturitas; 1996 May; 24(1-2):63-71. PubMed ID: 8794436
[TBL] [Abstract][Full Text] [Related]
9. Prevention of postmenopausal bone loss using tibolone or conventional peroral or transdermal hormone replacement therapy with 17beta-estradiol and dydrogesterone.
Lippuner K; Haenggi W; Birkhaeuser MH; Casez JP; Jaeger P
J Bone Miner Res; 1997 May; 12(5):806-12. PubMed ID: 9144347
[TBL] [Abstract][Full Text] [Related]
10. Transvaginal sonography of the endometrium in postmenopausal women: monitoring the effect of hormone replacement therapy.
Castelo-Branco C; Puerto B; Durán M; Gratacós E; Torné A; Fortuny A; Vanrell JA
Maturitas; 1994 May; 19(1):59-65. PubMed ID: 7935033
[TBL] [Abstract][Full Text] [Related]
11. Transvaginal ultrasonographic assessment of the endometrium in asymptomatic, postmenopausal women using different HRT regimens containing tibolone or estrogen.
Kurtay G; Berker B; Demirel C
J Reprod Med; 2004 Nov; 49(11):893-8. PubMed ID: 15603100
[TBL] [Abstract][Full Text] [Related]
12. Sequential combined transdermal and oral postmenopausal hormone replacement therapies: effects on bleeding patterns and endometrial histology.
Sendag F; Terek MC; Karadadas N
Arch Gynecol Obstet; 2001 Nov; 265(4):209-13. PubMed ID: 11789748
[TBL] [Abstract][Full Text] [Related]
13. Can endometrial protection be inferred from the bleeding pattern on combined cyclical hormone replacement therapy.
Burch D; Bieshuevel E; Smith S; Fox H
Maturitas; 2000 Feb; 34(2):155-60. PubMed ID: 10714910
[TBL] [Abstract][Full Text] [Related]
14. Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel-releasing intrauterine device or natural progesterone.
Suvanto-Luukkonen E; Malinen H; Sundström H; Penttinen J; Kauppila A
Acta Obstet Gynecol Scand; 1998 Aug; 77(7):758-63. PubMed ID: 9740525
[TBL] [Abstract][Full Text] [Related]
15. Endometrial safety and bleeding patterns during a 2-year study of 1 or 2 mg 17 beta-estradiol combined with sequential 5-20 mg dydrogesterone.
Ferenczy A; Gelfand MM; van de Weijer PH; Rioux JE
Climacteric; 2002 Mar; 5(1):26-35. PubMed ID: 11974556
[TBL] [Abstract][Full Text] [Related]
16. A 5-year study on the effect of hormone therapy, tibolone and raloxifene on vaginal bleeding and endometrial thickness.
Christodoulakos GE; Botsis DS; Lambrinoudaki IV; Papagianni VD; Panoulis CP; Creatsa MG; Alexandrou AP; Augoulea AD; Dendrinos SG; Creatsas GC
Maturitas; 2006 Mar; 53(4):413-23. PubMed ID: 16140483
[TBL] [Abstract][Full Text] [Related]
17. Effects of trimonthly progestin administration on the endometrium in elderly postmenopausal women who receive hormone replacement therapy: a pilot study.
Pinto AB; Binder EF; Kohrt WM; Bronder DR; Williams DB
Am J Obstet Gynecol; 2003 Jul; 189(1):11-5. PubMed ID: 12861131
[TBL] [Abstract][Full Text] [Related]
18. A comparative study of an estradiol-releasing vaginal ring versus tibolone in postmenopausal women: a transvaginal color Doppler study.
Botsis D; Kassanos D; Kalogirou D; Antoniou G; Karakitsos P; Zourlas PA
Maturitas; 1997 May; 27(1):77-83. PubMed ID: 9158081
[TBL] [Abstract][Full Text] [Related]
19. Transvaginal ultrasonography of the endometrium in women with postmenopausal bleeding: is it always necessary to perform an endometrial biopsy?
Gull B; Carlsson S; Karlsson B; Ylöstalo P; Milsom I; Granberg S
Am J Obstet Gynecol; 2000 Mar; 182(3):509-15. PubMed ID: 10739500
[TBL] [Abstract][Full Text] [Related]
20. Changes in the withdrawal bleeding pattern and endometrial histology during 17 beta-estradiol-dydrogesterone therapy in postmenopausal women: a 2 year prospective study.
van der Mooren MJ; Hanselaar AG; Borm GF; Rolland R
Maturitas; 1994 Dec; 20(2-3):175-80. PubMed ID: 7715470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
